08:50 VITAL BIOTECH<01164> - Results Announcement Vital BioTech Holdings Limited announced on 25/04/2005: (stock code: 01164 ) Year end date: 31/12/2004 Currency: HKD Auditors' Report: Unqualified (Audited ) (Audited ) Last Current Corresponding Period Period from 01/01/2004 from 01/01/2003 to 31/12/2004 to 31/12/2003 Note ('000 ) ('000 ) Turnover : 343,420 280,784 Profit/(Loss) from Operations : 42,129 75,742 Finance cost : (4,124) (4,680) Share of Profit/(Loss) of Associates : (112) N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : 32,776 61,142 % Change over Last Period : -46.39 % EPS/(LPS)-Basic (in dollars) 2 : 0.0221 0.04830 -Diluted (in dollars) : 0.0220 0.04800 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 32,776 61,142 Final Dividend 3 : N/A $0.015 per Share (Specify if with other : N/A with scrip option options) B/C Dates for Final Dividend : N/A Payable Date : N/A B/C Dates for Annual General Meeting : 26/05/2005 to 31/05/2005 bdi. Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1. Basis of preparation The accounts have been prepared in accordance with accounting principles generally accepted in Hong Kong and comply with accounting standards issued by the Hong Kong Institute of Certified Public Accountants ("HKICPA"). They have been prepared under the historical cost convention except that other investments are stated at fair value. The HKICPA has issued a number of new and revised Hong Kong Financial Reporting Standards and Hong Kong Accounting Standards (new "HKFRSs") which are effective for accounting periods beginning on or after 1 January 2005. The Group has not early adopted these new HKFRSs in the accounts for the year ended 31 December 2004. The Group has already commenced an assessment of the impact of these new HKFRSs but is not yet in a position to state whether these new HKFRSs would have a significant impact on its results of operations and financial position. 2. Earnings per share The calculations of basic and diluted earnings per share are based on the Group's profit attributable to shareholders of HK$32,776,000 (2003: HK$61,142,000). The basic earnings per share is based on the weighted average number of 1,480,993,084 (2003: 1,265,733,938) ordinary shares in issue during the year. The diluted earnings per share for the year ended 31 December 2004 is based on 1,486,685,939 (2003: 1,273,883,302) ordinary shares which are the weighted average number of 1,480,993,084 (2003: 1,265,733,938) ordinary shares in issue during the year plus the weighted average number of 5,692,855 (2003: 8,149,364) ordinary shares taking into account the effects of all dilutive potential ordinary shares. 3. Dividends 2004 2003 HK$'000 HK$'000 Interim dividend, paid, of HK0.5 cent (2003: HK1 cent) per ordinary share, with options of 1 scrip share for every 75 shares (2003: 45 shares) 7,496 12,775 Final dividend, proposed, of HK Nil cent (2003: HK1.5 cent per ordinary share, with options of 1 scrip share for every 55 shares) Nil 22,382 ------- --------- 7,496 35,157 ------- --------- ------- --------- The dividends have been partially settled by scrip shares as follows: Interim 526 10,896 Final N/A 1,354 For more details, please refer to the press announcement today.